Log-in / Create Account  
Session Information
2008 Midyear Clinical Meeting
Click here to go to the previous page
Clinical Trials in Gene Therapy: Science, Outcomes, and Implications for Pharmacy Practice
Track: Educational Sessions
Program Code: 255-L01
Date: Wednesday, December 10, 2008
Time: 8:00 AM to 9:50 AM EST
Location: S230H
MEETING PLANNING ASSOCIATE:
Susan Goodin, Pharm.D., BCOP, FCCP, Director, Division of Pharmaceutical Services, The Cancer Institute of New Jersey, New Brunswick, NJ
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 Jack Chen, PharmD, BCPS, CGP, Associate Professor (Neurology), Loma Linda University
Susan Goodin, Pharm.D., BCOP, FCCP, Director, Division of Pharmaceutical Services, The Cancer Institute of New Jersey, New Brunswick, NJ
Susan Johnston
Stephen Kay, Director
 John Petrich, RPh, MS, Investigational Drug Service Coordinator, Cleveland Clinic
Rowena Schwartz

  • Describe how gene therapy and pharmacogenetics differ and areas where these disciplines overlap.
  • Discuss the challenges and opportunities that gene therapy presents to pharmacy practice including management of investigational studies, and precautions for product preparation and handling.
  • Evaluate the outcomes of recent gene therapy clinical trials on melanoma and Parkinson's disease and define clinical areas where future research is expected.
  • Explain the science of gene therapy, including mechanisms of delivery and measures of clinical success.

Handout Online
(Code: 255-L01)
Regular Attendee: Free
Attendees Login